170 related articles for article (PubMed ID: 35387397)
1. Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy.
Verhoeven JGHP; Hesselink DA; Peeters AMA; de Jonge E; von der Thüsen JH; van Schaik RHN; Matic M; Baan CC; Manintveld OC; Boer K
Transpl Int; 2022; 35():10122. PubMed ID: 35387397
[No Abstract] [Full Text] [Related]
2. Histopathology, mRNA expression profile, and donor-derived cell-free DNA for assessment of rejection in pediatric heart transplantation.
O'Halloran CP; Tannous P; Arva NC; Thrush PT; Monge M; Joong A; Magnetta DA
Pediatr Transplant; 2024 May; 28(3):e14705. PubMed ID: 38528753
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free DNA to Detect Heart Allograft Acute Rejection.
Agbor-Enoh S; Shah P; Tunc I; Hsu S; Russell S; Feller E; Shah K; Rodrigo ME; Najjar SS; Kong H; Pirooznia M; Fideli U; Bikineyeva A; Marishta A; Bhatti K; Yang Y; Mutebi C; Yu K; Kyoo Jang M; Marboe C; Berry GJ; Valantine HA;
Circulation; 2021 Mar; 143(12):1184-1197. PubMed ID: 33435695
[TBL] [Abstract][Full Text] [Related]
4. A Novel High-throughput Droplet Digital PCR-based Indel Quantification Method for the Detection of Circulating Donor-derived Cell-free DNA After Kidney Transplantation.
Verhoeven JGHP; Boer K; Peeters AMA; Clahsen-van Groningen MC; Roodnat JI; van de Wetering J; Nieboer D; Bost DA; Baan CC; Hesselink DA
Transplantation; 2022 Sep; 106(9):1777-1786. PubMed ID: 35283452
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of plasma circulating donor DNA reflects cardiac graft injury: Report of two cases.
Dlouha D; Huckova P; Rohlova E; Vymetalova J; Novakova S; Hubacek JA
Biomed Rep; 2024 Mar; 20(3):50. PubMed ID: 38357233
[TBL] [Abstract][Full Text] [Related]
6. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.
Agbor-Enoh S; Tunc I; De Vlaminck I; Fideli U; Davis A; Cuttin K; Bhatti K; Marishta A; Solomon MA; Jackson A; Graninger G; Harper B; Luikart H; Wylie J; Wang X; Berry G; Marboe C; Khush K; Zhu J; Valantine H
J Heart Lung Transplant; 2017 Sep; 36(9):1004-1012. PubMed ID: 28624139
[TBL] [Abstract][Full Text] [Related]
7. Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.
Jang MK; Tunc I; Berry GJ; Marboe C; Kong H; Keller MB; Shah PD; Timofte I; Brown AW; Ponor IL; Mutebi C; Philogene MC; Yu K; Iacono A; Orens JB; Nathan SD; Agbor-Enoh S
J Heart Lung Transplant; 2021 Aug; 40(8):822-830. PubMed ID: 34130911
[TBL] [Abstract][Full Text] [Related]
8. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
[TBL] [Abstract][Full Text] [Related]
9. Donor-derived cell-free DNA: An independent biomarker in kidney transplant patients with antibody-mediated rejection.
Cheng D; Liu F; Xie K; Zeng C; Li X; Ni X; Ge J; Shu L; Zhou Y; Shi H; Liu H; Chen J
Transpl Immunol; 2021 Dec; 69():101404. PubMed ID: 33971294
[TBL] [Abstract][Full Text] [Related]
10. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
11. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.
Filippone EJ; Farber JL
Transplantation; 2021 Mar; 105(3):509-516. PubMed ID: 32732615
[TBL] [Abstract][Full Text] [Related]
12. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
[TBL] [Abstract][Full Text] [Related]
13. Plasma Donor-Derived Cell-Free DNA Levels Are Associated With the Inflammatory Burden and Macrophage Extracellular Trap Activity in Renal Allografts.
Guo L; Shen J; Lei W; Yan P; Wang M; Zhou Q; Wang H; Wu J; Chen J; Wang R
Front Immunol; 2022; 13():796326. PubMed ID: 35386710
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation.
Fernández-Galán E; Badenas C; Fondevila C; Jiménez W; Navasa M; Puig-Butillé JA; Brunet M
Liver Transpl; 2022 Feb; 28(2):257-268. PubMed ID: 34407295
[TBL] [Abstract][Full Text] [Related]
15. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.
Gielis EM; Ledeganck KJ; Dendooven A; Meysman P; Beirnaert C; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D
Nephrol Dial Transplant; 2020 Apr; 35(4):714-721. PubMed ID: 31106364
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
[TBL] [Abstract][Full Text] [Related]
17. Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.
Gielis EM; Beirnaert C; Dendooven A; Meysman P; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D; Ledeganck KJ
PLoS One; 2018; 13(12):e0208207. PubMed ID: 30521549
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy, a Potential New Detection Method in Heart Allograft Rejection.
Li C; Wang G
Methods Mol Biol; 2023; 2695():309-315. PubMed ID: 37450128
[TBL] [Abstract][Full Text] [Related]
19. Quantitative PCR of INDELs to measure donor-derived cell-free DNA-a potential method to detect acute rejection in kidney transplantation: a pilot study.
Dauber EM; Kollmann D; Kozakowski N; Rasoul-Rockenschaub S; Soliman T; Berlakovich GA; Mayr WR
Transpl Int; 2020 Mar; 33(3):298-309. PubMed ID: 31710731
[TBL] [Abstract][Full Text] [Related]
20. Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.
Agbor-Enoh S; Jackson AM; Tunc I; Berry GJ; Cochrane A; Grimm D; Davis A; Shah P; Brown AW; Wang Y; Timofte I; Shah P; Gorham S; Wylie J; Goodwin N; Jang MK; Marishta A; Bhatti K; Fideli U; Yang Y; Luikart H; Cao Z; Pirooznia M; Zhu J; Marboe C; Iacono A; Nathan SD; Orens J; Valantine HA; Khush K
J Heart Lung Transplant; 2018 Jul; 37(7):925-932. PubMed ID: 29500138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
